RT Journal Article
SR Electronic
T1 Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e000696
DO 10.1136/jitc-2020-000696
VO 8
IS 1
A1 Liu, Jieqiong
A1 Liu, Qiang
A1 Li, Ying
A1 Li, Qian
A1 Su, Fengxi
A1 Yao, Herui
A1 Su, Shicheng
A1 Wang, Quanren
A1 Jin, Liang
A1 Wang, Ying
A1 Lau, Wan Yee
A1 Jiang, Zefei
A1 Song, Erwei
YR 2020
UL http://jitc.bmj.com/content/8/1/e000696.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.